A detailed history of Wilson & Boucher Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wilson & Boucher Capital Management, LLC holds 56,343 shares of NVO stock, worth $4.92 Million. This represents 4.62% of its overall portfolio holdings.

Number of Shares
56,343
Previous 56,188 0.28%
Holding current value
$4.92 Million
Previous $8.02 Billion 16.35%
% of portfolio
4.62%
Previous 6.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$119.07 - $145.42 $18,455 - $22,540
155 Added 0.28%
56,343 $6.71 Billion
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $249,960 - $299,255
2,037 Added 3.76%
56,188 $8.02 Billion
Q1 2024

Apr 30, 2024

SELL
$102.11 - $135.92 $252,211 - $335,722
-2,470 Reduced 4.36%
54,151 $6.95 Billion
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $36,428 - $43,761
415 Added 0.74%
56,621 $5.86 Billion
Q3 2023

Nov 15, 2023

BUY
$90.94 - $199.54 $2.58 Million - $5.67 Million
28,423 Added 102.3%
56,206 $5.11 Billion
Q2 2023

Aug 09, 2023

BUY
$155.98 - $172.65 $17,937 - $19,854
115 Added 0.42%
27,783 $4.5 Billion
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $87,741 - $105,509
663 Added 2.46%
27,668 $4.4 Billion
Q4 2022

Jan 10, 2023

BUY
$102.55 - $135.33 $2,563 - $3,383
25 Added 0.09%
27,005 $3.66 Million
Q3 2022

Oct 21, 2022

BUY
$95.28 - $116.93 $47,640 - $58,465
500 Added 1.89%
26,980 $2.69 Million
Q2 2022

Jul 15, 2022

SELL
$103.24 - $121.81 $43,360 - $51,160
-420 Reduced 1.56%
26,480 $2.95 Million
Q1 2022

Apr 12, 2022

SELL
$93.1 - $112.54 $75,876 - $91,720
-815 Reduced 2.94%
26,900 $2.99 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $2.66 Million - $3.24 Million
27,715 New
27,715 $3.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wilson & Boucher Capital Management, LLC Portfolio

Follow Wilson & Boucher Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilson & Boucher Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilson & Boucher Capital Management, LLC with notifications on news.